WORK Medical Technology Group LTD Financials
This page shows WORK Medical Technology Group LTD (WOK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
WORK Medical Technology Group LTD's revenue declined 14.4% year-over-year, from $11.5M to $9.8M. This contraction results in a growth score of 0/100.
WORK Medical Technology Group LTD carries a low D/E ratio of 0.65, meaning only $0.65 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 87/100, indicating a strong balance sheet with room for future borrowing.
WORK Medical Technology Group LTD's current ratio of 1.71 indicates adequate short-term liquidity, earning a score of 48/100. The company can meet its near-term obligations, though with limited headroom.
WORK Medical Technology Group LTD converts 49.9% of revenue into free cash flow ($4.9M). This strong cash generation earns a score of 100/100.
WORK Medical Technology Group LTD passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, WORK Medical Technology Group LTD generates $-5.82 in operating cash flow ($6.2M OCF vs -$1.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
WORK Medical Technology Group LTD generated $9.8M in revenue in fiscal year 2025. This represents a decrease of 14.4% from the prior year.
WORK Medical Technology Group LTD generated $4.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 142.9% from the prior year.
WORK Medical Technology Group LTD reported -$1.1M in net income in fiscal year 2025. This represents an increase of 69.3% from the prior year.
WORK Medical Technology Group LTD earned $-0.04 per diluted share (EPS) in fiscal year 2025. This represents an increase of 85.2% from the prior year.
WORK Medical Technology Group LTD held $4.1M in cash against $0 in long-term debt as of fiscal year 2025.
WORK Medical Technology Group LTD's gross margin was 23.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.1 percentage points from the prior year.
WORK Medical Technology Group LTD's net profit margin was -10.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 19.5 percentage points from the prior year.
WORK Medical Technology Group LTD invested $435K in research and development in fiscal year 2025. This represents an increase of 43.9% from the prior year.
WORK Medical Technology Group LTD invested $1.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 85.6% from the prior year.
WOK Income Statement
| Metric | Q3'25 | Q2'25 | Q3'24 | Q3'23 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A |
WOK Balance Sheet
| Metric | Q3'25 | Q2'25 | Q3'24 | Q3'23 |
|---|---|---|---|---|
| Total Assets | $33.2M-4.5% | $34.7M-4.2% | $36.3M+21.0% | $30.0M |
| Current Assets | $20.5M-5.2% | $21.6M+3.6% | $20.8M-6.0% | $22.2M |
| Cash & Equivalents | $4.1M+104.9% | $2.0M-69.6% | $6.6M+310.9% | $1.6M |
| Inventory | $2.5M-17.5% | $3.0M-6.5% | $3.2M-31.1% | $4.6M |
| Accounts Receivable | $616K-29.8% | $877K-46.8% | $1.6M-50.5% | $3.3M |
| Goodwill | N/A | N/A | N/A | N/A |
| Total Liabilities | $12.0M-36.9% | $19.0M-5.9% | $20.2M+6.4% | $19.0M |
| Current Liabilities | $12.0M-36.9% | $19.0M-6.0% | $20.2M+6.6% | $18.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A |
| Total Equity | $18.3M+41.6% | $12.9M-1.8% | $13.2M+33.5% | $9.9M |
| Retained Earnings | $5.0M-18.6% | $6.1M+0.2% | $6.1M-36.6% | $9.6M |
WOK Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q3'24 | Q3'23 |
|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A |
WOK Financial Ratios
| Metric | Q3'25 | Q2'25 | Q3'24 | Q3'23 |
|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A |
| Current Ratio | 1.71+0.6 | 1.14+0.1 | 1.03-0.1 | 1.17 |
| Debt-to-Equity | 0.65-0.8 | 1.47-0.1 | 1.53-0.4 | 1.92 |
| FCF Margin | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is WORK Medical Technology Group LTD's annual revenue?
WORK Medical Technology Group LTD (WOK) reported $9.8M in total revenue for fiscal year 2025. This represents a -14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is WORK Medical Technology Group LTD's revenue growing?
WORK Medical Technology Group LTD (WOK) revenue declined by 14.4% year-over-year, from $11.5M to $9.8M in fiscal year 2025.
Is WORK Medical Technology Group LTD profitable?
No, WORK Medical Technology Group LTD (WOK) reported a net income of -$1.1M in fiscal year 2025, with a net profit margin of -10.9%.
What is WORK Medical Technology Group LTD's earnings per share (EPS)?
WORK Medical Technology Group LTD (WOK) reported diluted earnings per share of $-0.04 for fiscal year 2025. This represents a 85.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is WORK Medical Technology Group LTD's gross margin?
WORK Medical Technology Group LTD (WOK) had a gross margin of 23.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is WORK Medical Technology Group LTD's net profit margin?
WORK Medical Technology Group LTD (WOK) had a net profit margin of -10.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is WORK Medical Technology Group LTD's free cash flow?
WORK Medical Technology Group LTD (WOK) generated $4.9M in free cash flow during fiscal year 2025. This represents a 142.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is WORK Medical Technology Group LTD's operating cash flow?
WORK Medical Technology Group LTD (WOK) generated $6.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are WORK Medical Technology Group LTD's total assets?
WORK Medical Technology Group LTD (WOK) had $33.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are WORK Medical Technology Group LTD's capital expenditures?
WORK Medical Technology Group LTD (WOK) invested $1.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does WORK Medical Technology Group LTD spend on research and development?
WORK Medical Technology Group LTD (WOK) invested $435K in research and development during fiscal year 2025.
What is WORK Medical Technology Group LTD's current ratio?
WORK Medical Technology Group LTD (WOK) had a current ratio of 1.71 as of fiscal year 2025, which is generally considered healthy.
What is WORK Medical Technology Group LTD's debt-to-equity ratio?
WORK Medical Technology Group LTD (WOK) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is WORK Medical Technology Group LTD's return on assets (ROA)?
WORK Medical Technology Group LTD (WOK) had a return on assets of -3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is WORK Medical Technology Group LTD's Piotroski F-Score?
WORK Medical Technology Group LTD (WOK) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are WORK Medical Technology Group LTD's earnings high quality?
WORK Medical Technology Group LTD (WOK) has an earnings quality ratio of -5.82x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is WORK Medical Technology Group LTD?
WORK Medical Technology Group LTD (WOK) scores 59 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.